Stay updated on Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Deleted sponsor attribution and navigation links (H. Lee Moffitt Cancer Center and Research Institute; Moffitt Cancer Center Clinical Trials website; Helpful Links) from the study page. This reduces visible context about the study's sponsor and related resources, affecting how users identify provenance and access additional information.
    Difference
    0.2%
    Check dated 2026-02-18T06:56:44.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added. The notice about government funding lapse and the older Revision: v3.4.1 have been removed.
    Difference
    0.4%
    Check dated 2026-02-11T05:39:32.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A new site-wide notice informs users about a lapse in government funding and that the NIH Clinical Center is open, with links to cc.nih.gov and opm.gov for updates. Revision: v3.4.1 replaces the previous v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T05:38:29.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Show glossary feature is now available; new QC status labels 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted' appear, and the page revision is now 'Revision: v3.4.0', while older labels such as 'Last Update Submitted that met QC Criteria', 'Last Update Posted (Estimated)', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.
    Difference
    0.3%
    Check dated 2026-01-28T03:59:05.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The update is a minor site-version change (v3.3.4 added and v3.3.3 removed) with no impact on the study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:57:17.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The 'Last Update Posted' label on the Study Details page is now displayed as 'Last Update Posted (Estimated)', indicating the timestamp is approximate.
    Difference
    0.1%
    Check dated 2025-12-30T13:49:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page.